These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17196063)

  • 1. Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia.
    Leucht S; Kane JM
    J Clin Psychiatry; 2006 Nov; 67(11):1813-4. PubMed ID: 17196063
    [No Abstract]   [Full Text] [Related]  

  • 2. Definitions of the term 'recovered' in schizophrenia and other disorders.
    Faerden A; Nesvåg R; Marder SR
    Psychopathology; 2008; 41(5):271-8. PubMed ID: 18594161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia.
    Honer WG; Thornton AE; Sherwood M; MacEwan GW; Ehmann TS; Williams R; Kopala LC; Procyshyn R; Barr AM
    CNS Drugs; 2007; 21(9):699-714. PubMed ID: 17696571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Too good to be true? Aspirin and schizophrenia.
    Shader RI
    J Clin Psychopharmacol; 2012 Oct; 32(5):583-4. PubMed ID: 22926589
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel approach to measuring response and remission in schizophrenia in clinical trials.
    Aboraya A; Leucht S; Nasrallah HA; Samara M; Haro JM; Elshazly A; Zangeneh M
    Schizophr Res; 2017 Dec; 190():123-128. PubMed ID: 28314680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concepts of remission and recovery in schizophrenia.
    Leucht S; Lasser R
    Pharmacopsychiatry; 2006 Sep; 39(5):161-70. PubMed ID: 16944406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies to prevent relapse and encourage remission.
    Kane JM
    J Clin Psychiatry; 2007; 68 Suppl 14():27-30. PubMed ID: 18284275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.
    Nierenberg AA; DeCecco LM
    J Clin Psychiatry; 2001; 62 Suppl 16():5-9. PubMed ID: 11480882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining and achieving recovery from bipolar disorder.
    Harvey PD
    J Clin Psychiatry; 2006; 67 Suppl 9():14-8; discussion 36-42. PubMed ID: 16965184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of the development of recurrences of endogenous psychoses. The duration of remission in schizophrenia].
    Sverdlov LS; Skorik AI; Galanin IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(1):89-94. PubMed ID: 1647118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Kujawa et al. letter-to-the-editor.
    Sethuraman G; Taylor CC; Enerson M; Dunayevich E
    Schizophr Res; 2006 May; 84(1):172-3. PubMed ID: 16563702
    [No Abstract]   [Full Text] [Related]  

  • 14. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
    Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M;
    J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the concept of remission in schizophrenia.
    Leucht S; Beitinger R; Kissling W
    Psychopharmacology (Berl); 2007 Nov; 194(4):453-61. PubMed ID: 17618422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized remission criteria in schizophrenia.
    van Os J; Burns T; Cavallaro R; Leucht S; Peuskens J; Helldin L; Bernardo M; Arango C; Fleischhacker W; Lachaux B; Kane JM
    Acta Psychiatr Scand; 2006 Feb; 113(2):91-5. PubMed ID: 16423159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission in schizophrenia: critical and systematic review.
    AlAqeel B; Margolese HC
    Harv Rev Psychiatry; 2012; 20(6):281-97. PubMed ID: 23216066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.
    Frank E; Prien RF; Jarrett RB; Keller MB; Kupfer DJ; Lavori PW; Rush AJ; Weissman MM
    Arch Gen Psychiatry; 1991 Sep; 48(9):851-5. PubMed ID: 1929776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine in relapsed lymphoma: what is the optimal dose?
    Nabhan C
    Leuk Lymphoma; 2009 Jul; 50(7):1230-1; author reply 1232-4. PubMed ID: 19557647
    [No Abstract]   [Full Text] [Related]  

  • 20. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.